FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for carvedilol by Aurobindo Pharma Limited. This represents approval of a generic carvedilol product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension
• Post-myocardial Infarction

Drugs mentioned

• CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)